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Abstract
Ubiquitin plays the crucial roles to maintain the ubiquitin proteasome system 
(UPS) functions, which were suggested that involved in Parkinson’s diease (PD). 
Ubiquitin C-terminal hydrolase L1 (UCHL1), which was detected in Lewy bodies 
of nerve cells in PD brains, plays an important role for maintaining ubiquitin pool 
in UPS. The first UCHL1 mutation (UCHL1I93M) was found in two siblings of a 
PD family. By contrast, UCHL1S18Y mutation was recognized to reduce the risk of 
developing PD by its specific antioxidant protective function. The studies of UCHL1 
in mouse models showed that lack of UCHL1 resulted in motor ataxia, degenera-
tion of axons, and instability of free ubiquitin level. Transgenic mice expressing 
UCHL1I93M mutant exhibited dopaminergic neuron (DA) degeneration in MPTP-
treated conditions. In this chapter, we provide a summary on recent findings related 
to roles of UCH-L1 in PD. Knockdown dUCH, a homolog of human UCHL1, in fly 
dopaminergic neuron resulted as some Parkinson’s disease—like phenotype such as: 
(1) the underdevelopment and/or degeneration of DA neurons; (2) the shortage of 
dopamine in the brain; and (3) the locomotor dysfunctions. Those finding indicated 
that dUCH (ortholog of human UCH-L1 in Drosophila) plays an important role in 
Parkinson’s disease.
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1. Introduction
Parkinson’s disease (PD) was first described in 1817 by Dr. James Parkinson. PD 
is considered as the second most common neurodegenerative disease which impacts 
1% of the population over 60 years old [1]. The basic symptoms of Parkinson’s 
disease are difficulty walking, slow movement, stiff and trembling limbs, balance 
disorders, and facial paralysis. Symptoms appear gradually and are not marked; it 
is difficult to recognize and often may be confused with other diseases [2]. Causes 
are attributed to lack of dopamine, a chemical that plays an important role in nerve 
signal transmission, due to degeneration/loss of dopaminergic neurons. Besides, 
the presence of Lewy body was also reported as one of PD symptoms although it 
is not clear to be a cause or a result of PD [2–4]. The complex interaction between 
environmental and genetic factors is also thought to be a cause of PD. However, the 
interaction between these factors in the PD remains unclear [5]. Previous studies 
have shown that mitochondrial dysfunction, oxidative stress, altered protein prote-
olysis, and inflammation are responsible for PD pathogenesis [6–8]. In addition, the 
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relation to PD of many genes and their variants such as α-synuclein, PINK-1, DJ-1, 
LRRK2, and UCH-L1 has been reported  [9, 10].
Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is an abundant protein 
in neurons. The UCH-L1 polypeptide is 24,824 Da, contains 223 amino acids, 
and accounts for 1–2% of brain protein in humans [11]. In addition to the brain, 
UCH-L1 is also expressed strongly in the peripheral nervous system, including 
sensory and nervous system activity. UCH-L1 functions as an important enzyme 
in ubiquitin proteasome system. In a form of monomer, UCH-L1 hydrolyzes the 
peptide bond between two ubiquitin molecules [12]. In dimer form, it plays a 
function as a ligase [13]. However, the functions of UCH-L1 in living cell and 
tissue still remain unclear. UCH-L1 has been suggested to have its functions via 
the role of ubiquitin proteasome system by maintaining a pool of free ubiquitin 
molecules [14]. Dysfunction of UCH-L1 resulted in reduction of protein degrada-
tion, consequenced by the accumulation of ubiquitinated proteins which has been 
believed as the cause of cell degeneration [15–17]. UCH-L1, therefore, involves in 
many biological processes such as cell signaling, cell cycle, DNA repair, and other 
ubiquitination-dependent biological processes [14–16]. Consequently, UCH-L1 
had been reported as close relevant to neurodegenerative diseases, diabetes, as well 
as cancer [14–16, 18].
2. UCH-L1 in Parkinson’s disease
In PD, there are some evidences which reveal that ubiquitin carboxyl-terminal 
hydrolase L1 (UCH-L1 or PGP9.5) is associated with PD. First, an UCH-L1I93M 
mutant was identified in two siblings from a German family with autosomal 
dominant PD in 1998 [18]. After that, UCH-L1S18Y mutant was discovered by 
Lincoln et al. [19]. UCH-L1S18Y mutant, in some cases, has been believed to have 
the potential in decreasing the risk of developing PD [20, 21] by its specific antioxi-
dant protective function [22]. Moreover, UCH-L1 is also localized in Lewy bodies 
[23]; inclusions were found in nerve cells of PD. Although UCH-L1 had shown to 
have close link to PD, roles of the protein in PD are still controversial. Previous 
studies showed that not all mutant carriers manifest the phenotype of PD or show 
the protective effect to PD. The homozygous mutation of UCH-L1 (UCH-L1E7A), 
which also shows the decrease in hydrolytic activity, was found in three siblings of 
a Turkish family with progressive visual loss due to optic atrophy but neither the 
patients homozygous for UCH-L1E7A nor their heterozygous parents or siblings 
exhibited PD features on neurological examination [24]. In addition, Healy et al. 
and Ragland et al. showed that UCH-L1S18Y does not exhibit any protective effects 
against PD [25, 26].
Recently, research on UCH-L1 cellular and animal models has revealed many 
important findings of UCH-L1 functions in PD. An in-frame deletion of UCH-L1 
gene encoding a truncated UCH-L1 lacking catalytic residue [17] in gracile axonal 
dystrophy (gad) mouse exhibits some PD pathogenesis such as locomotor ataxia, 
tremor, and difficulty in moving, and these symptoms are progressively severe [27]. 
Analysis of transcriptomic, proteomic, and histochemical in the brain of gad mouse 
revealed some prominent genes and proteins, which contribute to PD pathogenesis 
[28–30].
In PD research, Drosophila melanogaster has served as a valuable model to get 
insight into important features of PD pathogenesis [31–33]. The Drosophila model 
of PD provided a useful tool for tracking the integrity of the whole dopaminergic 
neuron system, analyzing neurodegeneration with a large number of animals to 
study PD in the population level, high-throughput genetic and drug screening. 
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In our study, knockdown Drosophila homolog of human UCH-L1 (dUCH) in dopa-
minergic neuron system of the fly brain exerted a fly model of Parkinson’s disease 
[34]. The fly model mimics all of the main PD-related symptoms including locomo-
tor behaviors, dopamine production, DA neuron integrity, as well as the progression 
of DA neuron degeneration.
2.1  Loss function of UCH-L1 homolog in Drosophila melanogaster resulted in 
locomotor dysfunction, one of most important PD phenotypes
Parkinson’s disease is the most common movement disorder which is normally 
featured by motor symptoms. These symptoms include tremor, rigidity, bradyki-
nesia, and postural instability. In the early stage of Drosophila development, the 
effects of dUCH knockdown on the third instar larval wandering behavior were 
examined by crawling assay. Heterozygous dUCH knockdown larvae displayed 
a tremor-like behavior which was tracked as tight wavy line when moving hori-
zontally on agar plates. Additionally, these larvae accomplished a shorter moving 
path (Figure 1A, right panel) comparing to driver controls (Figure 1A, left 
panel) in an identical interval of time. The mean velocity of knockdown larvae 
was reduced to 62% of the controls (Figure 1B). The reduction was statistically 
significantly different when comparing two means (Student’s t test with Welch’s 
correction, N= 10, p< 0.01). In the adult stage, dUCH knockdown resulted in 
decline locomotion of Drosophila. Both knockdown and control flies showed 
age-related decline in the climbing ability (Figure 1C). However, the climbing 
ability of knockdown flies dropped sharply at day 25 and led to the difference 
between the control and knockdown to statistically significance at this time 
Figure 1. 
The dysfunction in locomotor behavior of dopaminergic neuron-specific dUCH knockdown flies. (A) Motion 
paths of control larvae (TH) and dUCH knockdown larvae (TH>dUCH-IR). Knockdown larvae exhibit 
shorter and disorder crawling paths (right panel) compared to control (left panel). (B) Crawling velocity of 
control (TH) and knockdown larvae (TH>dUCH-IR). Knockdown larvae show the reduction in crawling 
pace and parametric unpaired t test with Welch’s correction: ** p < 0.01, error bars present SD. (C) The 
climbing ability of control (TH) and dUCH knockdown adult flies (TH>dUCH-IR). Knockdown flies start to 
exhibit the decline in the climbing ability at day 25 after eclosion (repeated measures two-way ANOVA with 
Bonferroni’s post hoc test, **p < 0.01, ***p < 0.001, ****p < 0.0001; error bars present SEM). (D) Survival 
curve of control (TH) and dUCH knockdown (TH>dUCH-IR). Control and knockdown flies do not show 
the difference in survival (Kaplan-Meier method with log-rank test, p > 0.05. TH (+; +; TH-GAL4/+), and 
TH>dUCH-IR (+; +; TH-GAL4/UAS-dUCH-IR)).
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point (repeated measures two-way ANOVA with Bonferroni’s post hoc test, 
p < 0.0001). The decline in climbing function of knockdown flies still sustained 
on day 30 onward (repeated measures two-way ANOVA with Bonferroni’s post 
hoc test, p < 0.001 at day 30 and p < 0.01 at days 35 and 40) and was struck down 
to 0% at day 40 in which no fly can climb across 10 ml mark in 10 s (Figure 1C). 
Furthermore, the survival analysis was carried out to determine the toxicity of 
the reduction of dUCH. There is no significant difference in survival curve of 
control and knockdown flies (Kaplan-Meier method with log-rank test, p > 0.05) 
(Figure 1D). It illustrated that the knockdown of dUCH played no effect on 
Drosophila life span. The analysis also proved that there were no effects of death 
events in climbing analysis. Taken together, those data demonstrated that the 
reduction of dUCH specifically in dopaminergic neurons of Drosophila melanogas-
ter leads to the disorder in crawling behavior and decline in locomotor ability but 
does not affect Drosophila’s life span.
2.2  Loss function of UCH-L1 homolog in Drosophila melanogaster exerted PD 
phenotype of dopaminergic neuron degeneration
Forno [35] and Thomas [2] have shown that locomotor dysfunction in PD 
patients may be caused by the degeneration of dopaminergic neurons (DA neurons) 
[2, 35]. These neurons play important roles in dopamine production for central 
nervous system and control multiple functions of the brain including voluntary 
movement. In Drosophila, the locomotor deficit was observed in many PD-related 
genes such as SNCA [36], LRRK2 [37], and PARKINR275W [37] ectopic expres-
sion followed by the degeneration of DA neurons. The study of Budnik and White 
showed that DA neurons assembled into some different clusters with the differences 
in projection and number of DA neurons [38]. In addition, DA neurons in PPL2 
cluster in adult brain were demonstrated to originate from DL2a cluster [39]. It 
seems to be that the development of DA neurons not only occurs in embryonic to 
larval stages but also in larval to adult stages. In Drosophila model of PD, dopami-
nergic neurons in both larval and adult dUCH knockdown brains showed its degen-
eration. The DA neuronal system in the third instar larval brain lobe was classified 
into six clusters: DM1a, DM1b, DM2, DL1, DL2a, and DL2b (Figure 2A) [38, 39]. 
The pattern, shape, and number of DA neurons in most of clusters in dUCH knock-
down and control are similar except on DL1 cluster (Figure 2B). In DL1 cluster, 
dUCH knockdown brain (TH>dUCH-IR) exhibited the reduction in numbers of DA 
neurons compared to driver control (TH). It indicates that the reduction of dUCH 
may cause the incomplete loss or underdevelopment of DA neurons in DL1 clusters 
of the third instar larval central brain.
On the other hand, in the adult Drosophila, when dUCH was specifically 
knocked down in dopaminergic neurons, the PPM2 dopaminergic cluster lost its 
neurons (Figure 3A2, A2’ and A3, A3’). This loss occurred in 1-day-old flies, 
increased progressively by age, reached 50% on age 20, and affected all the indi-
viduals of 40-day-old flies (Figure 3A4). In PPM3 dopaminergic cluster, the neuron 
loss occurred in 1-day-old flies with highly prevalence proportion nearly 40% of the 
population (Figure 3B2, B2’, B3). The number of PD disease—like flies—reached 
50% as early as 10 days old and got nearly maximum prevalence on the age of 20 
(Figure 3B3). In PPL2 dopaminergic cluster, the loss of a specific neuron was seen 
in knockdown brain TH>dUCH-IR (Figure 3C2, C2’) compared to TH-GAL4 
control TH (Figure 3C1, C1’). DA neuron in PPL2 cluster was lost in highly preva-
lence proportion; 40% of knockdown flies exhibited DA loss at 1 day old. However, 
unlike PPM3 cluster the number of disease flies increased steadily through the age 
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and reached maximum prevalence on the age of 40 (Figure 3C3). The DA neu-
ron susceptibility to dUCH reduction depended on the age and neuronal type of 
Drosophila adult brain.
2.3  Loss function of UCH-L1 homolog in Drosophila melanogaster resulted in 
dopamine shortage
The reduction of neurotransmitter, dopamine, was observed in PD patients’ 
brain which has been thought to be a direct cause leading to PD symptoms. The 
production of dopamine mainly occurs in DA neurons according to catecholamine 
biosynthesis pathway (Figure 4A). In addition, studies on Drosophila model have 
demonstrated that some Drosophila life activities such as locomotor activity [33, 40], 
olfactory conditioning [41], sleep and arousal regulation [42–44], and memory and 
learning process [45, 46] involve dopamine (Figure 4B). In the Drosophila model 
of PD, the underdevelopment or degeneration of DA neurons was detected in the 
brain of dUCH knockdown flies. Therefore, the dopamine level in the brain of 
knockdown flies may be affected by these impairments. Quantification of dopamine 
in dUCH knockdown brain showed that dopamine was reduced at every time point 
of examination (1, 10, 15, 20, and 25 days after eclosion) in dUCH knockdown flies 
compared to driver control (Figure 4C) (ordinary two-way ANOVA with Tukey’s 
multiple comparisons test, ****p < 0.0001). The statistical analysis indicated that 
there is no significant difference in the amount of dopamine at every time point in 
the driver control flies. However, there are significant differences in the dopamine 
level from days 1 to 10 and 20 to 25 in the knockdown flies (ordinary two-way 
ANOVA with Tukey’s multiple comparisons test, ***p < 0.001, *p < 0.05). The data 
Figure 2. 
The abnormality in the number of DL1 dopaminergic neurons in dUCH knockdown larval brain. (A) A 
schematic representation of six DA neuron clusters DM1a, DM1b, DM2, DL1, DL2a, and DL2b and projection 
in Drosophila larval central brain were redrawn based on the study of Blanco et al. [39]. (B) Representative 
confocal images show that DA neuron clusters in the third instar larval central brain were stained with 
anti-TH (green). The whole brain was counterstained with anti-DLG (red). The heterozygous driver control 
TH-GAL4/+ (TH) on the left panel (B1, B2, B3, B3’) and heterozygous dUCH knockdown TH-GAL4/
UAS-dUCH-IR (TH>dUCH-IR) on the right panel (B4, B5, B6, B6’). The boxed area in merge image (B3, 
B6) marks that DL1 cluster was magnified in (B’3, B’6), respectively. The number of DA neurons in DL1 
clusters in dUCH knockdown brain was less than those in driver control (B’3, B’6). (C) Quantification of DA 
neurons in each cluster in driver control (black bars) and dUCH knockdown (gray bars). Only the difference 
in the number of DA neurons in DL1 clusters between dUCH knockdown and driver control was significantly 
different (parametric unpaired Student’s t-test with Welch’s correction, ***p < 0.001, n = 6). Scale bars, 50 μm. 
DA neuron, dopaminergic neuron; DM, dorsal medial; DL, dorsal lateral; TH, tyrosine hydroxylase; DLG, 
Drosophila discs large.
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indicated that knockdown of dUCH leads to the reduction of dopamine beginning 
at the first day of eclosion and continuing on the following days. Interestingly, there 
are two significant periods (1 to 10 and 20 to 25 days) showed the reduction of dopa-
mine in dUCH knockdown brain which may involve in the DA neuron integrity. The 
reduction of dopamine in dUCH knockdown flies suggested the connection between 
DA neuron impairment and locomotor deficit. These results can be modeled as the 
reduction of dUCH caused the impairment of DA neurons which leads to the reduc-
tion of dopamine followed by the dysfunction in locomotor behaviors (Figure 4D).
Figure 3. 
The susceptibility of DA neurons in each cluster depends on age and neuronal type. Confocal images showed 
TH-positive neurons in PPM2 (A1–A3), PPM3 (B1–B2), and PPL2 (C1–C3) clusters in adult central brain. 
The prevalence proportion of dUCH knockdown flies on each cluster was described as a progressive graph, 
PPM2 (A4), PPM3 (B3), and PPL2 (C4). In PPM2 cluster, two kinds of partial loss of DA neurons (two 
to three neurons) were observed in heterogeneous dUCH knockdown flies TH>dUCH-IR (A2, A2’; A3, A3’) 
compared to heterogeneous driver control TH-GAL4 (TH) (A1, A1’). The prevalence of PPM2 in dUCH 
knockdown flies increased with age; 20-day-old flies reached nearly 50% of population. In PPM3 cluster, the loss 
of two DA neurons was specifically seen in knockdown flies (B2, B2’) compared to control (B1, B1’). However, 
the number of flies with this loss rose dramatically and reached 50% of population before 10 days old (B3). 
The loss also occurred partially in a specific DA neurons in PPL2 cluster in knockdown flies (C2, C2’; C3, C3’) 
compared to TH-GAL4 control (C1, C1’). Loss of DA neurons in PPL2 cluster happened steadily through aging 
brain was described in C4; 50% of population suffered from PPL2 DA neuron loss around 20 days old (C4).
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3. Material and methods
3.1 Fly stocks
Fly stocks were maintained at 25°C on standard food containing 0.7% agar, 
5% glucose, and 7% dry yeast. Wild-type strain Canton-S was obtained from the 
Bloomington Drosophila Stock Center (BDSC). RNAi lines carrying UAS-dUCH-IR 
fusion (GD#26468) for knockdown Drosophila ubiquitin carboxyl-terminal hydro-
lase (dUCH, CG4265) were received from the Vienna Drosophila Resource Center 
(VDRC). GAL4 drivers were used to perform the targeted knockdown of dUCH in 
dopaminergic neuron of D. melanogaster: TH-GAL4 (BDSC#8848).
3.2 Immunostaining
Larval and adult brains were dissected in cold phosphate-buffered saline (PBS) 
and fixed in 4% paraformaldehyde at 25°C for 15 min. After washing with 0.3% 
PBS-T (PBS containing 0.3% Triton-X100) twice, the samples were blocked in 
blocking solution (0.15% PBS-T containing 10% normal goat serum) at 25°C for 
20 min. Samples were then incubated with the following primary antibodies diluted 
in blocking solution: rabbit anti-Drosophila ubiquitin carboxyl-terminal hydrolase 
(anti-dUCH; 1:500) at 4°C for 16 h or rabbit anti-tyrosine hydroxylase (anti-TH; 
1:250; Millipore, AB152) at 4°C for 20 h. After washing with 0.3% PBS-T, samples 
Figure 4. 
Dopamine shortage in adult dUCH knockdown brain. (A) The production of dopamine through catecholamine 
biosynthesis pathway in DA neuron. (B) The functions of dopamine in life activities of fruit fly [40, 41, 43–46]. (C) 
The quantity of dopamine per fly head in dUCH knockdown (TH>dUCH-IR) and driver control (TH). Knockdown 
flies show the reduction of dopamine in the brain in every time point compared to driver control (two-way ANOVA 
with Tukey’s multiple comparisons test, ****p < 0.0001). Knockdown flies also show the reduction of the dopamine 
level in 1- to 10- and 20- to 25-day period (two-way ANOVA with Tukey’s multiple comparisons test, ***p < 0.001, 
*p < 0.05). (D) The intermediate role of dopamine in the process of DA neuron impairment to locomotor deficit.
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were incubated with secondary antibodies conjugated with Alexa 488 or FITC 
(1,500; Invitrogen) at 25°C for 2 h and then washed and mounted in Vectashield 
Antifade Mounting Medium (Vector Laboratories, Japan). Finally, the samples were 
inspected by a confocal laser scanning microscope (Olympus Fluoview FV10i) or 
Olympus BX41 Microscope.
3.3 Crawling assay
Male larvae in the early third instar stage were collected randomly and washed 
with PBS to discard food traces. After that, larvae were transferred to agar plates 
containing 2% agar with a density of two to four larvae per plate. The movement of 
larvae was recorded by a digital camera for 60 s. The recorded videos were then con-
verted into the AVI type by MOV to AVI converter (Pazera Jacek, Poland) and then 
analyzed by ImageJ (NIH, USA) with wrMTrck plugin (developed by Dr. Jesper 
Søndergaard Pedersen) to track larval movement and draw motion paths.
3.4 Climbing assay
Newly eclosed adult male flies were collected and transferred to conical tubes 
which have heights of 15 cm and diameters of 2 cm. After that, the tubes were 
tapped to collect the flies to the bottom, and the length of time to record the 
movement of flies was 30 s. The procedures were repeated five times and recorded 
by a digital camera. For all of the climbing experiments, the height which each fly 
climbed to was scored as follows: 0 (less than 2 cm), 1 (between 2 and 4 cm), 2 
(between 4 and 6 cm), 3 (between 6 and 8 cm), 4 (between 8 and 10 cm), and 5 
(more than 10 cm). The climbing assay was performed every 5 days until all flies 
lose their locomotor abilities.
3.5 Dopamine quantification
Dopamine quantification procedure was performed as described [45] with the 
following modifications. Thirty fly heads were homogenized in 600 μl homogeniza-
tion buffer (0.1 M perchloric acid/3% trichloroacetic acid) on ice and sonicated 
5 times for 30 s each and then placed on ice for 30 min. Debris were removed by 
centrifugation at 15,000 g for 15 min at 4°C. Fifty microliter of supernatant was uti-
lized for HPLC analysis using Nanospace SI-2 (Shiseido, Japan) with running buffer 
containing 180 mM chloroacetic acid, 50 μM EDTA, 160 mM sodium hydroxide, 
and 8.5% acetonitrile. Sample was separated in CapCell Pak C18 UG120 column 
(Shiseido, Japan) at 0.5 ml/min flow rate. Dopamine was electrochemically detected 
by Electrochemical Detector 3005 (Shiseido, Japan). Dopamine (H8502, Sigma-
Aldrich) was used to build the standard curve at 0.0025, 0.005, 0.01, 0.02, and 
0.04 μM. The differences in the dopamine level of examined samples were statisti-
cally analyzed using ordinary two-way ANOVA with Tukey’s multiple comparison 
test and graphed by GraphPad Prism 6.0 (GraphPad Software, USA).
4. Conclusion and perspective
Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is a protein that may play 
multiple roles in the cell through the effect on ubiquitin system. UCH-L1 had been 
found as a PD-related protein. However, the exact mechanism remains unclear. In the 
Drosophila model, specific knockdown dUCH in dopaminergic neuron exerted PD-lie 
phenotypes including locomotor dysfunctions, DA degeneration, and dopamine 
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shortage. Interestingly, the degeneration of DA neurons in dUCH knockdown adult 
brain which occurred progressively and severely during the course of aging mimics 
the epidemiology of PD. These results provided one more evidence of the UCH-L1 in 
PD and suggest that the dUCH knockdown Drosophila is a promising model for study-
ing both PD pathogenesis and epidemiology. The major advantages of the Drosophila 
model are a complex nervous system with DA neuron clusters and a conservation of 
the basic biological process and PD-related genes and can exhibit many PD features. 
The Drosophila model also can be utilized for either high-throughput screen.
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